|
Eiko Lifesciences Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
74.63 Cr.
|
P/BV
|
1.32
|
Book Value (Rs.)
|
41.36
|
|
52 Week High/Low (Rs.)
|
75/42
|
FV/ML
|
10/1
|
P/E(X)
|
35.46
|
|
Bookclosure
|
27/09/2024
|
EPS (Rs.)
|
1.53
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 26.39 | 9.73 | 3.23 |
| Total Income From Operations | 26.39 | 9.73 | 3.23 |
| | | | |
| EXPENDITURE | | | |
| Consumption of Raw Materials | 23.05 | 7.31 | 1.78 |
| Increase/Decrease in Stocks | 0.50 | -0.39 | 0.61 |
| Employees Cost | 0.26 | 3.31 | 0.43 |
| Depreciation | 0.49 | 0.14 | 0.13 |
| Other Expenses | 1.14 | 3.14 | 0.80 |
| Total Expenses | 25.43 | 13.52 | 3.76 |
| | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 0.96 | -3.78 | -0.52 |
| Other Income | 0.49 | 0.10 | 0.03 |
| P/L Before Interest, Excpt. Items & Tax | 1.45 | -3.69 | -0.49 |
| Interest | 0.09 | 0.21 | 0.11 |
| P/L Before Exceptional Items & Tax | 1.36 | -3.90 | -0.59 |
| P/L Before Tax | 1.36 | -3.90 | -0.59 |
| Tax | 0.35 | -1.02 | -0.15 |
| P/L After Tax from Ordinary Activities | 1.00 | -2.88 | -0.44 |
| Net Profit/Loss For the Period | 1.00 | -2.88 | -0.44 |
| Share Of P/L Of Associates | 0.07 | 0.00 | 0.00 |
| Net P/L After Minority Interest & Share Of Associates | 1.08 | -2.88 | -0.44 |
| | | | |
| Equity Share Capital | 12.87 | 3.82 | 3.82 |
| EPS Before Extra Ordinary * | | | |
| Basic EPS (Rs.) | 0.82 | -3.92 | -0.72 |
| Diluted EPS (Rs.) | 0.82 | -3.92 | -0.72 |
| EPS After Extra Ordinary * | | | |
| Basic EPS (Rs.) | 0.82 | -3.92 | -0.72 |
| Diluted EPS (Rs.) | 0.82 | -3.92 | -0.72 |
| | | | |
| PBITOE Margin (%) | 3.63 | -38.86 | -16.16 |
| PBTE Margin (%) | 5.13 | -40.08 | -18.35 |
| PBT Margin (%) | 5.13 | -40.08 | -18.35 |
| PAT Margin (%) | 3.79 | -29.62 | -13.61 |
| PAT After MI And SOA Margin (%) | 4.07 | -29.62 | -13.61 |
